- You can view the full Eli Lilly and Ratings Report.
- Use our drugs section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
This big pharmaceutical player's recent woes could be good news for its rivals, but it also poses risks for investors.
Eli Lilly built up much false hope by being far too bullish on its now-failed Alzheimer treatment, Cramer said.